ストックスクリーナーアプリを入手
2.93
2.80%
0.07
前日終値:
$2.86
開ける：
$2.96
24時間の取引高:
324.35K
Relative Volume:
0.59
時価総額：
$109.98M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+9.29%
1か月 パフォーマンス:
+58.06%
6か月 パフォーマンス:
+98.65%
1年 パフォーマンス:
+50.00%
1日の値動き範囲:
$2.73
$2.98
1週間の範囲:
$2.71
$3.28
52週間の値動き範囲:
$1.23
$4.92
Metagenomi Inc Stock (MGX) Company Profile
MGX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MGX
Metagenomi Inc
|
2.9301 | 107.34M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
406.76 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.17 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
551.62 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
809.47 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.09 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Metagenomi Inc Stock (MGX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-05-07 | 開始されました | H.C. Wainwright | Buy |
| 2024-05-02 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-03-05 | 開始されました | BMO Capital Markets | Outperform |
| 2024-03-05 | 開始されました | Chardan Capital Markets | Buy |
| 2024-03-05 | 開始されました | JP Morgan | Overweight |
| 2024-03-05 | 開始されました | Jefferies | Buy |
| 2024-03-05 | 開始されました | TD Cowen | Outperform |
| 2024-03-05 | 開始されました | Wells Fargo | Overweight |
すべてを表示
Metagenomi Inc (MGX) 最新ニュース
Using Ichimoku Cloud for Metagenomi Inc. technicals2025 Geopolitical Influence & Free Technical Pattern Based Buy Signals - newser.com
Chart overlay techniques for tracking Metagenomi Inc.July 2025 Momentum & Community Consensus Picks - newser.com
Will Metagenomi Inc. stock go up soonJuly 2025 Trends & Low Risk Growth Stock Ideas - newser.com
Will Metagenomi Inc. stock see insider buyingBull Run & Safe Capital Growth Plans - newser.com
Metagenomi's (MGX) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
What candlestick patterns are forming on Metagenomi Inc.2025 Risk Factors & AI Forecasted Entry and Exit Points - newser.com
What recovery options are there for Metagenomi Inc.Market Rally & Long-Term Growth Stock Strategies - newser.com
Measuring Metagenomi Inc.’s beta against major indicesTrade Analysis Summary & Weekly Market Pulse Updates - newser.com
How Metagenomi Inc. stock performs in rate cut cyclesWeekly Trade Analysis & AI Enhanced Market Trend Forecasts - newser.com
Why Metagenomi Inc. stock could outperform in 20252025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - newser.com
Custom watchlist performance reports with Metagenomi Inc.Quarterly Earnings Report & Safe Capital Growth Stock Tips - newser.com
Detecting support and resistance levels for Metagenomi Inc.July 2025 Weekly Recap & Weekly High Potential Alerts - newser.com
Best data tools to analyze Metagenomi Inc. stockEarnings Recap Summary & Community Supported Trade Ideas - newser.com
Why Metagenomi Inc. stock could be next big winner2025 Volume Leaders & Community Verified Watchlist Alerts - newser.com
Metagenomi (NASDAQ:MGX) versus SCYNEXIS (NASDAQ:SCYX) Head-To-Head Analysis - Defense World
What technical signals suggest for Metagenomi Inc. stockJuly 2025 Trade Ideas & Daily Risk Controlled Trade Plans - newser.com
Can you recover from losses in Metagenomi Inc.Market Movement Recap & Accurate Entry and Exit Point Alerts - newser.com
Metagenomi, Inc. Enters into A Non-Exclusive License Agreement with Acuitas Therapeutics, Inc - MarketScreener
Goldman Sachs Group Inc. Trims Stock Position in Metagenomi, Inc. $MGX - Defense World
Metagenomi Inc (MGX) 財務データ
Metagenomi Inc (MGX) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.95%
大文字化:
|
ボリューム (24 時間):